BioPharmX (BPMX) Tops Q1 EPS by 1c

BioPharmX (NYSE: BPMX) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17).

Cash and cash equivalents as of April 30, 2016, were $4.0 million.

For earnings history and earnings-related data on BioPharmX (BPMX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c